Abbonarsi

IMAGING OF LUNG TRANSPLANTATION - 08/09/11

Doi : 10.1016/S0272-5231(05)70257-4 
Jo-Anne O. Shepard, MD *

Riassunto

The first human lung transplantation was performed in 1963 but was unsuccessful. When cyclosporine was introduced in the early 1980s, the era of solid organ transplantation began. The first long-term success with human single lung transplantation, which was modeled on the concepts established for heart–lung transplantation at Stanford University, occurred in 1983 at the Toronto General Hospital. In 1986, the technique for double lung transplantation was successfully developed. The field of lung transplantation has evolved dramatically in the past 16 years. 2, 15, 21, 26, 32, 37, 50, 52, 53, 70, 72 One-year survival after lung transplantation is now 80% to 90% and 5-year survival is approximately 50%.21 The operative mortality rate is less than 10%. Lung transplantation is now an accepted treatment for a large number of end-stage pulmonary diseases, including, but not limited to, emphysema, cystic fibrosis, pulmonary fibrosis, sarcoidosis, lymphangioleiomyomatosis, and primary pulmonary hypertension.

Several factors have led to the ultimate success of lung transplantation, including (1) improved recipient assessment and selection, (2) improved intensive care unit care, (3) better understanding of the mechanism of rejection and refinements in immunosuppressive regimens, (4) improved prevention, diagnosis, and treatment of infections, (5) improved surgical techniques to overcome problems of airway ischemia, and (6) development of effective rehabilitation programs.

Major challenges remain, however. 18, 19 The major obstacle to the growth of lung transplant programs is the limited supply of suitable donors. Only 20% to 30% of multi-organ donors have lungs that are suitable for transplantation because of the high incidence of complications such as aspiration pneumonia, atelectasis, and the pulmonary edema associated with donor brain death. More recently, the harvest of lower lobes from two living donors for double lung transplant has been performed successfully by several groups, thereby shortening the wait for a suitable donor.67 The development of obliterative bronchiolitis in up to 50% of long-term survivors remains another major challenge. Obliterative bronchiolitis is the major factor affecting long-term survival and quality of life. 32, 35

Several complications pertain specifically to lung transplant recipients, including airway ischemia, reperfusion edema, infections, acute rejection, obliterative bronchiolitis and other postoperative problems related to surgical technique and immunosuppressive therapy. Imaging procedures play an important role in the diagnosis and management of these problems. This article focuses on the imaging appearance of these complications.*

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Address reprint requests to Jo-Anne O. Shepard, MD, Department of Radiology–FND 202, Massachusetts General Hospital, Boston, MA 02114


© 1999  W. B. Saunders Company. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.© 1998  © 1998  © 1998  © 1999  © 1998 
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 20 - N° 4

P. 827-844 - dicembre 1999 Ritorno al numero
Articolo precedente Articolo precedente
  • INTERVENTIONAL TECHNIQUES IN THE THORAX
  • Jeffrey S. Klein
| Articolo seguente Articolo seguente
  • RADIOLOGIC EVALUATION OF EMPHYSEMA FOR LUNG VOLUME REDUCTION SURGERY
  • Ella A. Kazerooni

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.